Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03323034
Title Pevonedistat, Irinotecan Hydrochloride, and Temozolomide in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphoma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Children's Oncology Group

central nervous system cancer

Advanced Solid Tumor



Irinotecan + MLN4924 + Temozolomide

Age Groups: child | adult
Covered Countries USA

No variant requirements are available.